This study can also be of great help to follow-up studies aiming to evaluate the effect of FGF21 on atherosclerosis, the associated mechanisms, and the effects of combination with other novel antidiabetic medications, such as GLP-1 analogues and SGLT-2 inhibitors. This evidence concerns the gene GCG and atherosclerosis.